Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2830-2836

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Igau, B.
Right arrow Articles by Fiévet, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Igau, B.
Right arrow Articles by Fiévet, C.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2830-2836.)
© 1997 American Heart Association, Inc.


Articles

In Vivo Glucosylated LpA-I Subfraction

Evidence for Structural and Functional Alterations

Bruno Igau; Graciela Castro; Véronique Clavey; Christian Slomianny; Régis Bresson; Pierre Drouin; Jean-Charles Fruchart; ; Catherine Fiévet

From Serlia et INSERM U325-1 rue du Professeur Calmette, Institut Pasteur de Lille, Lille, France (B.I., G.C., V.C., J.C.F.); INSERM U42 - Certia, Villeneuve d'Ascq, France (C.S.);. Centre Hospitalier de Douai, Douai, France (R.B.); and Service de Diabétologie, Chu de Nancy et CIC INSERM du Chu de Nancy, Nancy, France (P.D.).

Correspondence to Catherine Fiévet, Serlia et INSERM U325-1 rue du Professeur Calmette, Institut Pasteur de Lille, 59019 Lille, France.

Abstract This study compared the structural and functional properties of glucosylated and non-glucosylated LpA-I particle subfractions (GLpA-I and NGLpA-I, respectively) isolated from patients with poorly controlled type 1 (insulin-dependent) diabetes. Compared with NGLpA-I, GLpA-I showed an enrichment in triglycerides (P<.05) and a depletion in phospholipid (P<.05) content. Moreover, the triglycerides-to-cholesteryl esters ratio was increased (P<.05), suggesting an increased cholesteryl ester transfer protein activity and a possible transport defect that accelerates atherogenesis. The surface-to-core constituents ratio, an indirect estimate of particles size, is lower in GLpA-I (P<.01) than in NGLpA-I, correlating well with a larger median size (P<.05) as seen by electron microscopy. The apolipoprotein (apo) A-I conformation was evaluated through determination of the immunological accessibility of three different domains defining specific epitopes for anti-apo A-I monoclonal antibodies. We observed a marked decreased accessibility for two of these regions, which interestingly have already been implicated in the interaction with cells. Cell culture data suggest that nonenzymatic glycosylation occurring on apo A-I can modify lipoprotein function, since it results in a decreased binding of GLpA-I to HeLa cells and impaired cholesterol efflux from Fu5AH rat hepatoma cells.


Key Words: glucosylation • LpA-I lipoprotein particles • reverse cholesterol transport • atherosclerosis